GLP-1 Hair Loss in Men: What the New NYU Study Found

The short answer

In the big Wegovy and Zepbound trials, hair loss was rare in men: under 1% of men on the drug reported it, compared with 4% to 7% of women. A September 2026 NYU Langone study in the Journal of Investigative Dermatology found that men whose genes give them more GLP-1 receptor activity had about 7% higher odds of male pattern baldness, but it was a genetic study, not a trial of people taking the drugs. Most hair loss on GLP-1 is still temporary shedding linked to fast weight loss, so steady protein and strength training matter, and Sharpy keeps both simple.

Men on Ozempic, Wegovy, Mounjaro or Zepbound want to know one thing: is my hairline going to pay for this? In the main trials, hair loss in men was rare, under 1%. A new NYU study adds a twist: men whose genes give them more GLP-1 receptor activity had about 7% higher odds of male pattern baldness. That is a genetic signal, not proof that the shots make men bald. Here is what the labels and the study say, and how to tell normal shedding from the kind that sticks.

What the NYU study on GLP-1 and male pattern baldness found

The study came out in the Journal of Investigative Dermatology on September 3, 2026, from a team at NYU Langone Health led by Lynn Petukhova, PhD. It was back in the headlines this week (Muscle & Fitness, October 21, 2026).

The team did not follow men on GLP-1 drugs. They used Mendelian randomization. Some people are born with gene variants that make the GLP-1 receptor (GLP1R) more active. That is a natural, lifelong version of what the drugs do. The researchers checked whether men with those variants have more androgenetic alopecia, the medical name for male pattern baldness.

Study detail What it was
Journal Journal of Investigative Dermatology (online Sept 3, 2026)
Method Two-sample Mendelian randomization (genes as a stand-in for the drug)
Gene data eQTLGen, 31,684 people
Hair loss data 205,327 people, mostly white men
Main finding About 7% higher odds of male pattern baldness with higher GLP1R activity
Checked against High blood pressure, insulin resistance, lower testosterone (the link held)
Funding NIH grants R01AR080796 and K01AR075111

What this study does and does not prove

  • It does suggest that GLP-1 receptor activity itself may play a part in pattern baldness, apart from weight loss.
  • It does not measure hair loss in people taking semaglutide or tirzepatide.
  • It does not tell you your own risk. The 7% is a change in odds, not "7 out of 100 men go bald."
  • It only looked at men, mostly white men, so it may not apply to everyone.

The authors say more experiments are needed. Petukhova said that if those work out, men could one day be screened for hair loss risk before they start a GLP-1.

How often men lose hair on Wegovy and Zepbound

The FDA labels split hair loss by sex. Men reported it far less often than women.

Drug and dose Men on drug Men on placebo Women on drug Women on placebo
Wegovy 2.4 mg (weight-loss trials) 0.9% 0% 4% 2%
Wegovy 7.2 mg 0.2% 0% 8.4% 1.5%
Zepbound (pool of 2 weight-loss trials) 0.5% 0% 7.1% 1.3%

Both labels say the hair loss "was associated with weight reduction." In the Zepbound trials, no one on the drug stopped treatment because of it.

So the trial data and the gene study tell slightly different stories. The trials, which lasted about 68 to 72 weeks, saw very little hair loss in men. Pattern baldness builds over years, so a trial that short may be too brief to catch a small push in that direction. Both can be true.

Why men lose hair on GLP-1: two different problems

1. Shedding from fast weight loss (telogen effluvium)

This is the common one. A big shock to the body, like eating far less and losing weight fast, pushes many hairs into their resting phase at once. About 2 to 4 months later, they fall out together.

  • Thinning is spread over the whole scalp
  • More hair in the drain, on the pillow or in the comb
  • It usually grows back once weight and eating settle

Our main hair loss on GLP-1 guide covers this in detail.

2. Male pattern baldness (androgenetic alopecia)

This is the one the NYU study is about. It is driven by genes and hormones.

  • A receding hairline at the temples
  • Thinning at the crown
  • Slow, over months and years
  • Does not grow back on its own

According to NYU, it affects about half of white American men over 50 anyway. That makes it hard to tell, for one man, whether a GLP-1 sped it up or it was coming regardless.

Sign Shedding Pattern baldness
Where Whole scalp Temples, hairline, crown
Speed Sudden, weeks Slow, years
Timing 2 to 4 months after fast weight loss Any time, often starts in 20s to 40s
Grows back? Usually, in months Not without treatment

How to protect your hair on a GLP-1

You cannot change your genes. You can control the things that make shedding worse.

Eat enough protein. Hair is made of protein, and a low appetite makes it easy to fall short. Set a daily protein number and hit it most days. The protein target guide shows how to work out yours.

Lift weights. Strength training helps protect muscle while you lose fat, and slower, steadier fat loss is easier on your body. The beginner strength program needs no gym.

Do not crash diet on top of the drug. Very low calorie days add stress. Eat real meals even when you are not hungry.

Check your labs. Ask your doctor about iron (ferritin), vitamin D, zinc and thyroid. Low levels can cause shedding on their own.

Skip the miracle pills. Biotin only helps people who are low in it, which is rare, and high doses can throw off some blood tests. Read our GLP-1 supplements guide before you buy anything.

The hardest part is doing the protein and the lifting every day when you barely want to eat. Sharpy gives you one daily protein target, one 20-minute workout and a Shape Score, so you can see that you are losing fat and keeping muscle, not just watching the scale.

When to see a doctor about hair loss

Book a visit with your doctor or a dermatologist if:

  • Your hairline or crown is clearly changing
  • Shedding lasts more than 6 months
  • You see patches, redness, scaling or pain on the scalp
  • You also feel very tired, cold or short of breath (possible low iron or thyroid issue)

For male pattern baldness, the FDA-approved treatments are topical minoxidil and oral finasteride. A dermatologist can tell you if either fits you and how they would work with your other medicines. Do not stop, skip or lower your GLP-1 because of hair worries without talking to your prescriber first. Weight loss often brings bigger health gains than a few months of shedding costs.

The bottom line

For most men on a GLP-1, hair loss is uncommon and, when it happens, usually temporary shedding from fast weight loss. The NYU study is a new and real signal that GLP-1 receptor activity may nudge male pattern baldness, but it is early, genetic evidence, not a trial result. Watch your hairline, eat your protein, keep lifting and talk to a dermatologist early if the pattern changes. Sharpy helps with the daily part: protein, a 20-minute workout and a Shape Score that shows the fat coming off and the muscle staying on.

This guide is general information, not medical advice.

Sources

Questions people ask

Does GLP-1 cause hair loss in men?

It can, but it is uncommon. In the Wegovy 2.4 mg weight-loss trials, 0.9% of men on the drug reported hair loss versus 0% on placebo. In the Zepbound trials, it was 0.5% of men versus 0% on placebo. Both labels say the hair loss was associated with weight reduction.

What did the NYU study on GLP-1 and male pattern baldness find?

Researchers at NYU Langone used Mendelian randomization, a method that uses genes as a stand-in for a drug effect. Men with gene variants that raise GLP-1 receptor activity had about 7% higher odds of androgenetic alopecia (male pattern baldness). The link held after accounting for blood pressure, insulin resistance and testosterone. It was published in the Journal of Investigative Dermatology on September 3, 2026.

Does Ozempic cause hair loss in men?

Ozempic's diabetes trials did not single out hair loss, but Wegovy contains the same medicine, semaglutide, at a higher dose. On Wegovy 2.4 mg, 0.9% of men reported hair loss. On Wegovy 7.2 mg, it was 0.2% of men. The NYU study suggests a small genetic link to pattern baldness, but it did not test Ozempic users directly.

Is GLP-1 hair loss permanent?

Shedding after fast weight loss (telogen effluvium) usually grows back once weight and eating settle, often over several months. Male pattern baldness is different: it is gradual and does not grow back on its own. If you see a receding hairline or a thinning crown, see a dermatologist early.

How can I tell shedding from male pattern baldness?

Shedding is spread over the whole scalp and shows up as more hair in the shower or on the pillow, usually 2 to 4 months after a big change. Pattern baldness follows a shape: the temples, the hairline and the crown, and it moves slowly over years. A dermatologist can tell them apart with a scalp exam.

What is the treatment for GLP-1 hair loss in men?

For shedding, the main fixes are enough protein and calories, and checking iron, vitamin D and thyroid with your doctor. For male pattern baldness, the FDA-approved options are topical minoxidil and oral finasteride. Ask a dermatologist which, if any, fits you. Do not stop or change your GLP-1 dose on your own.

Read next